<DOC>
	<DOCNO>NCT01694576</DOCNO>
	<brief_summary>By clinical trial , investigator try give answer question . Whether NPC patient stag N2-3M0 need adjuvant chemotherapy consist paclitaxel platinum concurrent chemoradiation ?</brief_summary>
	<brief_title>NPC Staged N2-3M0 : Adjuvant Chemotherapy Just Observation After Concurrent Chemoradiation</brief_title>
	<detailed_description>Recent research ( Lancet Oncology 2012 ) show survival benefit achieve add adjuvant chemotherapy concurrent chemoradiation patient locoregionally advanced NPC . But patient even high risk distant metastasis ( stag N2-3M0 ) , adjuvant chemotherapy necessary ?</detailed_description>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Nedaplatin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>1. pathologically confirm untreated NPC patient stag N23M0 2. age : 18y 65y 3. MRI examination 4 . ECOGâ‰¤2 5. write consent 1. without second cancer 2. pregnancy 3. severe disease ( blood , liver , kidney heart disease ) 4. could stag properly 5. without write consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Nasopharyngeal carcinoma stag N2-3M0</keyword>
	<keyword>Adjuvant chemotherapy</keyword>
</DOC>